Seasonal and Climatic Influence on Respiratory Infections in Children with Cystic Fibrosis

Overview

Journal Sci Rep

Specialty Science

Date 2024 Nov 7

PMID 39511324

Authors

Julie Mesinele

Manon Ruffin

Loic Guillot

Pierre-Yves Boelle

Harriet Corvol

Affiliations

Soon will be listed here.

Abstract

Pseudomonas aeruginosa (Pa) and Methicillin susceptible Staphylococcus aureus (MSSA) are the predominant bacteria found in the airways of people with cystic fibrosis (pwCF), significantly contributing to lung disease progression. While various factors influencing the initial acquisition (IA) of these pathogens are known, the impact of environmental conditions remains understudied. This epidemiological study assessed the risk of MSSA and Pa initial acquisitions in relation to seasonality and climatic zones among 1,184 French pwCF under 18 years old. The age at IA for Pa (Pa-IA) and MSSA (MSSA-IA) was estimated using the Kaplan-Meier method. Seasonality and climatic zones were analysed as risk factors using time-varying Cox regression models. The median age at MSSA-IA was notably earlier (2.0 years) than that at Pa-IA (5.1 years). MSSA-IA occurred increasingly younger in more recent birth cohorts, while the age at Pa-IA remained stable over time. The risk of Pa-IA was consistently higher in all seasons compared with spring, peaking in autumn (HR = 1.53), irrespective of climatic zones. In Oceanic and Continental climates, the highest risk for MSSA-IA was in winter (HRs = 1.45 and 1.20 respectively). In the Mediterranean climate, the risk of MSSA-IA was lower in winter compared to spring (HRs = 0.68 and 0.61 respectively), and the median age at MSSA-IA later than for Pa-IA. This study demonstrates that seasonality and meteorological factors may influence acquisition of MSSA and Pa in pwCF. These findings suggest that environmental factors play a role in pathogen acquisition dynamics in CF and could inform the development of preventive strategies.

References

Muhlebach M, Jiang X, Kosorok M, Klein E, Saiman L . Longitudinal changes and regional variation of incident infection rates at cystic fibrosis centers, United States 2010-2016. J Cyst Fibros. 2021; 21(1):34-39. DOI: 10.1016/j.jcf.2021.08.009. View

Carson S, Psoter K, Koehler K, Siklosi K, Montemayor K, Toporek A . Indoor air pollution exposure is associated with greater morbidity in cystic fibrosis. J Cyst Fibros. 2021; 21(2):e129-e135. PMC: 8918065. DOI: 10.1016/j.jcf.2021.08.015. View

Qiu Y, Zhou Y, Chang Y, Liang X, Zhang H, Lin X . The Effects of Ventilation, Humidity, and Temperature on Bacterial Growth and Bacterial Genera Distribution. Int J Environ Res Public Health. 2022; 19(22). PMC: 9691097. DOI: 10.3390/ijerph192215345. View

Psoter K, DE Roos A, Wakefield J, Mayer J, Rosenfeld M . Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Clin Microbiol Infect. 2013; 19(11):E483-9. DOI: 10.1111/1469-0691.12272. View

Cutting G . Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. 2014; 16(1):45-56. PMC: 4364438. DOI: 10.1038/nrg3849. View

Asner S, Waters V, Solomon M, Yau Y, Richardson S, Grasemann H . Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis. J Cyst Fibros. 2012; 11(5):433-9. PMC: 7105203. DOI: 10.1016/j.jcf.2012.04.006. View

Warrier R, Skoric B, Vidmar S, Carzino R, Ranganathan S . The role of geographical location and climate on recurrent Pseudomonas infection in young children with Cystic Fibrosis. J Cyst Fibros. 2019; 18(6):817-822. DOI: 10.1016/j.jcf.2019.04.013. View

Salsgiver E, Fink A, Knapp E, LiPuma J, Olivier K, Marshall B . Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis. Chest. 2015; 149(2):390-400. PMC: 5831653. DOI: 10.1378/chest.15-0676. View

De Sario M, Katsouyanni K, Michelozzi P . Climate change, extreme weather events, air pollution and respiratory health in Europe. Eur Respir J. 2013; 42(3):826-43. DOI: 10.1183/09031936.00074712. View

10.

McIsaac S, Stadnyk A, Lin T . Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis. J Leukoc Biol. 2012; 92(5):977-85. DOI: 10.1189/jlb.0811410. View

11.

Musken M, Di Fiore S, Dotsch A, Fischer R, Haussler S . Genetic determinants of Pseudomonas aeruginosa biofilm establishment. Microbiology (Reading). 2009; 156(Pt 2):431-441. DOI: 10.1099/mic.0.033290-0. View

12.

Schaupp L, Addante A, Voller M, Fentker K, Kuppe A, Bardua M . Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis. Eur Respir J. 2023; 62(2). DOI: 10.1183/13993003.02153-2022. View

13.

Marguet C, Houdouin V, Pin I, Reix P, Huet F, Mittaine M . Chest physiotherapy enhances detection of in nonexpectorating children with cystic fibrosis. ERJ Open Res. 2021; 7(1). PMC: 7938055. DOI: 10.1183/23120541.00513-2020. View

14.

Sheikh S, Britt Jr R, Ryan-Wenger N, Khan A, Lewis B, Gushue C . Impact of elexacaftor-tezacaftor-ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis. Pediatr Pulmonol. 2022; 58(3):825-833. PMC: 9957929. DOI: 10.1002/ppul.26261. View

15.

Cho J, Tiedje J . Biogeography and degree of endemicity of fluorescent Pseudomonas strains in soil. Appl Environ Microbiol. 2000; 66(12):5448-56. PMC: 92480. DOI: 10.1128/AEM.66.12.5448-5456.2000. View

16.

Johansen H, Hoiby N . Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax. 1992; 47(2):109-11. PMC: 463585. DOI: 10.1136/thx.47.2.109. View

17.

Brugha R, Edmondson C, Davies J . Outdoor air pollution and cystic fibrosis. Paediatr Respir Rev. 2018; 28:80-86. DOI: 10.1016/j.prrv.2018.03.005. View

18.

Psoter K, De Roos A, Wakefield J, Mayer J, Rosenfeld M . Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis. BMC Infect Dis. 2017; 17(1):411. PMC: 5466772. DOI: 10.1186/s12879-017-2511-9. View

19.

Mesinele J, Ruffin M, Guillot L, Corvol H . Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier Genes. Int J Mol Sci. 2022; 23(22). PMC: 9698440. DOI: 10.3390/ijms232214205. View

20.

Psoter K, DE Roos A, Wakefield J, Mayer J, Bryan M, Rosenfeld M . Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Epidemiol Infect. 2015; 144(5):1075-83. DOI: 10.1017/S0950268815002411. View